Since MAO-B is the main isoform present in brain (Riederer et al., 1978; Sonsalla and Golbe, 1988) and inhibition of MAO-B proved to be useful as therapeutic approach in PD, focus has mainly been targeted toward MAO-B inhibition in AD (Thomas, 2000). Here, MAOB is linked to Alzheimer disease.